Clinical Trial Update: A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports on the 6-month efficacy and safety of Org 50081 in adults with chronic primary insomnia; results have been posted. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Sleep Initiation and Maintenance Disorders

Drugs mentioned

• Org 50081

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Sleep Initiation and Maintenance Disorders, Mental Disorders | Phase 3 | Status: COMPLETED | Results posted: 2014-08-01